首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Chemiluminescence resonance energy transfer biosensing platform for site-specific determination of DNA methylation and assay of DNA methyltransferase activity using exonuclease III-assisted target recycling amplification
【24h】

Chemiluminescence resonance energy transfer biosensing platform for site-specific determination of DNA methylation and assay of DNA methyltransferase activity using exonuclease III-assisted target recycling amplification

机译:化学发光共振能量转移生物传感平台,用于DNA甲基化的位点确定和使用核酸外切酶III辅助的靶标回收扩增测定DNA甲基转移酶活性

获取原文
获取原文并翻译 | 示例
           

摘要

Site-specific determination of DNA methylation and assay of MTase activity can be used for determining specific cancer types, providing insights into the mechanism of gene repression, and developing novel drugs to treat methylation-related diseases. Herein, we develop a simple and highly sensitive chemiluminescence (CL) biosensing platform for site-specific determination of DNA methylation using Exonuclease III (Exo III)-assisted target recycling signal amplification. After bisulfite treatment of mixture of methylated DNA and unmethylated DNA, methylated DNA can hybridize with fluorescein (FAM)- labeled probe DNA to form double-stranded DNA (dsDNA), removing the FAM-labeled probe DNA from the surface of grapheme oxide, and the chemiluminescence resonance energy transfer (CRET) sensing signal can be observed and then amplified using Exo III-based recycling strategy. The biosensing platform exhibits excellent high sensitivity, and it can ever distinguish as low as 0.002% methylation level from the mixture, which is superior to most currently reported methods used for DNA methylation assay. In addition, the proposed method can also be used to sensitively assay MTase activity with determination limit of 0.007 U/mL. This CL biosensing offers the advantages of being facile, sensitive, rapid and cost-effective. These features make the system promising for future use for early cancer diagnosis and discover of new anticancer drugs.
机译:DNA甲基化的位点特异性测定和MTase活性测定可用于确定特定的癌症类型,提供有关基因抑制机制的见识,并开发治疗甲基化相关疾病的新药。在本文中,我们开发了一种简单且高度灵敏的化学发光(CL)生物传感平台,用于使用核酸外切酶III(Exo III)辅助的靶标回收信号放大来特异性检测DNA甲基化。在亚硫酸氢盐处理了甲基化DNA和未甲基化DNA的混合物后,甲基化DNA可以与荧光素(FAM)标记的探针DNA杂交形成双链DNA(dsDNA),从氧化石墨烯的表面去除FAM标记的探针DNA,然后可以观察化学发光共振能量转移(CRET)传感信号,然后使用基于Exo III的回收策略进行放大。该生物传感平台具有出色的高灵敏度,并且可以从混合物中分辨出低至0.002%的甲基化水平,这优于目前报道的大多数用于DNA甲基化分析的方法。此外,所提出的方法还可以用于测定极限为0.007 U / mL的MTase活性。这种CL生物传感具有简便,灵敏,快速且经济高效的优势。这些功能使该系统有望用于将来的早期癌症诊断和发现新的抗癌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号